Announcements
Keep up to date with Isogenica’s latest news on collaborations and press releases.
Isogenica’s
Latest News
PRESS RELEASES
Isogenica and Frederick National Laboratory for Cancer Research add two more projects to their contractual relationship
UK-based antibody engineering experts Isogenica are proud to announce a new collaboration with the Frederick National Laboratory for Cancer Research in Maryland USA.
Arvinas teams up with Isogenica using our CIS display technology to expand their PROTAC® platform
Announcing a new collaboration with Arvinas Isogenica is pleased to announce a technology license agreement with Arvinas, who will leverage Isogenica’s CIS Display technology in support of advancing...
Isogenica and Frederick National Laboratory for Cancer Research team up to discover novel antibody therapeutics
UK-based antibody engineering experts Isogenica are proud to announce a new collaboration with the Frederick National Laboratory for Cancer Research in Maryland USA.
Announcements
Catch up on Isogenica’s latest activities.
Why is Cancer so Hard? Marion Cubbitt tell us her thoughts…
Researchers have been trying to fight cancer for over 100 years, yet there’s still no cure. What makes treating cancer so challenging? We asked our Director of Discovery for her views…
Isogenica turns 25: Our journey
We’ve come a long way over the past quarter century, from our early years as a therapeutic peptide discovery company to specialising in VHH antibodies. Here’s the story…
PEGS 2022: Isogenica showcases plans for implementing machine learning tools
As part of our KTP partnership between Aston University and Nottingham University, we’re developing and integrating an ML-assisted pipeline for faster discovery and optimisation of VHH antibodies for next-generation biotherapeutics.